A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Study sponsor: Ironwood Pharmaceuticals, Inc. · IRWD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-01-23Actual
Enrollment · participants98Actual
Source updated2025-02-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.